OGI

Organigram Holdings

1.16 USD
+0.00
0.00%
At close Apr 25, 4:00 PM EDT
After hours
1.14
-0.02
1.72%
1 day
0.00%
5 days
11.54%
1 month
8.41%
3 months
-24.18%
6 months
-37.30%
Year to date
-30.12%
1 year
-37.63%
5 years
-82.84%
10 years
-96.29%
 

About: Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

Employees: 1,093

0
Funds holding %
of 7,419 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

295% more call options, than puts

Call options by funds: $462K | Put options by funds: $117K

129% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 7

13% more funds holding

Funds holding: 71 [Q3] → 80 (+9) [Q4]

1.1% less ownership

Funds ownership: 6.7% [Q3] → 5.6% (-1.1%) [Q4]

14% less capital invested

Capital invested by funds: $13.2M [Q3] → $11.4M (-$1.78M) [Q4]

17% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 18

Research analyst outlook

We haven’t received any recent analyst ratings for OGI.

Financial journalist opinion

Based on 5 articles about OGI published over the past 30 days

Neutral
Business Wire
2 days ago
Organigram Global's Products Recognized at the CNB Awards
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, is pleased to announce that three of its consumer brands — SHRED, Edison, and Trailblazer — earned honours at the recent CNB Leadership Conference and the Cannabis NB Cup. Inspired by the legacy events that have shaped cannabis culture over the years, the Cannabis NB Cup celebrates the best in grow — with winners chosen by those who matter mos.
Organigram Global's Products Recognized at the CNB Awards
Neutral
Business Wire
4 days ago
Organigram Global Shares Recording of its OG Investor Session
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram Global”), Canada's #1 cannabis company by market share, is pleased to share the full recording of its recently held OG Investor Session, now available online for shareholders, analysts, and industry stakeholders. To access a recording of the event please click here or visit www.organigram.ca/investors. “This session was a way for Organigram to engage directly with investors and industry stak.
Organigram Global Shares Recording of its OG Investor Session
Neutral
Business Wire
1 week ago
New Abacus Data Poll Reveals that Most Canadians See Cannabis as a Key Pillar of Canada's Economic Future
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, today released new public opinion data showing strong national support for growing Canada's economy through homegrown industries, including the legal cannabis sector. The national survey, commissioned by Organigram Global and conducted by Abacus Data between April 3–8, 20251, arrives at a pivotal moment for Canada's economic and political futu.
New Abacus Data Poll Reveals that Most Canadians See Cannabis as a Key Pillar of Canada's Economic Future
Neutral
Business Wire
3 weeks ago
Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram Global”), the cannabis leader in Canada by market share, is pleased to announce its inaugural virtual investor event, the OG Investor Session, taking place on April 10, 2025, at 4pm EST. This online event offers investors a front-row seat to Organigram Global's next chapter. Attendees will gain valuable insights into the Company's growth trajectory, engage directly with leadership on key ind.
Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ
Neutral
Business Wire
3 weeks ago
Organigram Enters U.S. Through Acquisition of Collective Project Beverages
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, is pleased to announce the acquisition of 100% of the issued and outstanding shares of Collective Project Limited (“CPL”) for upfront consideration of approximately C$6.2 million, potential milestone payments and potential earnout payments totaling in the aggregate up to C$24M for the twelve-month periods ending September 30, 2025 and Septembe.
Organigram Enters U.S. Through Acquisition of Collective Project Beverages
Neutral
Business Wire
1 month ago
Organigram Unveils Bold New Brand Identity Reflecting Market Leadership Position in Canada and Growing International Presence
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is proud to announce its official rebrand to Organigram Global Inc. (“Organigram Global”), a move that demonstrates the Company's evolution from an East Coast medical cannabis company into a burgeoning global cannabis leader. Having achieved the number one position in market share in Canada1 and established a growing international footprint, Orga.
Organigram Unveils Bold New Brand Identity Reflecting Market Leadership Position in Canada and Growing International Presence
Neutral
Business Wire
1 month ago
Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of Name Change to Organigram Global Inc.
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and special meeting of shareholders (the “Shareholders”) held virtually on March 24, 2025 (the “Meeting”). Shareholder Approval of the Name Change and Articles of Amendment At the Meeting, a special resolution approving an amendment to the articles of the Company to change the name of the Company to “Organigram Global Inc.” (the.
Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of Name Change to Organigram Global Inc.
Neutral
Business Wire
1 month ago
Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that on February 28, 2025, the Company closed the third and last of three tranches (the “Third Tranche”) of the previously announced C$124,559,674 follow-on strategic equity investment (the “Investment”) by BT DE Investments Inc. (the “Investor”), a wholly owned subsidiary of British American Tobacco plc (“BAT”). Pursuant to the T.
Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment
Positive
Seeking Alpha
2 months ago
Organigram Reports In-Line Q1 Results As Cannabis Sector Tanks
Organigram reported improved financial results for Q1-2025. OGI expects revenue to increase for Q2 as well as cash positions. OGI:CA sees growth in its international cannabis sales and Canadian sales.
Organigram Reports In-Line Q1 Results As Cannabis Sector Tanks
Positive
Seeking Alpha
2 months ago
Organigram Is A Small-Cap Bargain
Organigram's stock has declined significantly, but my bullish outlook remains due to strong fundamentals, strategic investments, and potential acquisition by British American Tobacco. The company reported a 17% revenue growth in Q1 FY24, driven by international expansion and the Motif Labs acquisition, despite missing expectations. Organigram's balance sheet is robust with C$46.8 million in cash, no debt, and a healthy current ratio of 3.3X, mitigating many risks.
Organigram Is A Small-Cap Bargain
Charts implemented using Lightweight Charts™